Thyropath Liquid
NDC Package 64578-0133-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Thyropath (avena sativa, borago officinalis, calcarea carbonica, chelidonium majus, ferrum iodatum, fucus vesiculosus, glandula suprarenalis suis, hepar suis, iodium, kali iodatum, phosphoricum acidum, pituitarum posterium (bovine), pyridoxinum hydrochloricum, thyroidinum (bovine), zincum metallicum) liquids is classified as a

administered via oral route. This formulation utilizes a liquid delivery system. Marketed by Energetix Corporation, this product is identified by NDC 64578-0133.

Identification & Billing

NDC Package Code
64578-0133-1
Package Description
59.1 mL in 1 BOTTLE, DROPPER
Product Code
64578-0133
11-Digit Billing Format
64578013301

Clinical Specifications

Proprietary Name
Thyropath
Non-Proprietary Name
Avena Sativa, Borago Officinalis, Calcarea Carbonica, Chelidonium Majus, Ferrum Iodatum, Fucus Vesiculosus, Glandula Suprarenalis Suis, Hepar Suis, Iodium, Kali Iodatum, Phosphoricum Acidum, Pituitarum Posterium (bovine), Pyridoxinum Hydrochloricum, Thyroidinum (bovine), Zincum Metallicum
Substance Name
Avena Sativa Flowering Top; Borage; Bos Taurus Pituitary Gland, Posterior; Chelidonium Majus; Ferrous Iodide; Fucus Vesiculosus; Iodine; Oyster Shell Calcium Carbonate, Crude; Phosphoric Acid; Pork Liver; Potassium Iodide; Pyridoxine Hydrochloride; Sus Scrofa Adrenal Gland; Thyroid, Bovine; Zinc
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Energetix Corporation
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-15-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64578-0133-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Thyropath, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains avena sativa flowering top; borage; bos taurus pituitary gland, posterior; chelidonium majus; ferrous iodide; fucus vesiculosus; iodine; oyster shell calcium carbonate, crude; phosphoric acid; pork liver; potassium iodide; pyridoxine hydrochloride; sus scrofa adrenal gland; thyroid, bovine; zinc as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on November 15, 2016. The current certification is valid through December 31, 2026.

How is this Energetix Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578013301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
64578-0133-1
11-Digit CMS (5-4-2)
64578-0133-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.